Obesity is a global pandemic. According to the World Health Organization (WHO), adult obesity in the world more than doubled ...

to challenge the supremacy of tirzepatide and semaglutide. These molecules are also approved to treat Type 2 Diabetes ("T2D"), as Mounjaro/Ozempic respectively, earnings a combined >$20bn in this ...

The European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug ... device that requires no titration and is approved for ...

Chairman's Statement Overview The Company's Net Asset Value (NAV) underperformed the reference index (the FTSE World Europe ex UK Index) over the six months under review, ending the period only ...

Demand for Wegovy (semaglutide) has been rocketing since ... a body mass index of 35 or more and a concomitant illness like diabetes, or a BMI of 30 or more and a referral to NHS weight-loss ...

Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type ...

A novel investigational endoscopic procedure targeting the duodenum appears beneficial in improving glycemic parameters in ...